Jack Kaye
Director/Board Member chez DYADIC INTERNATIONAL, INC.
Fortune : 188 259 $ au 31/03/2024
Profil
Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc., an Independent Non-Executive Director at uniQure NV, and a Director at DiaCarta, Inc. Previously, he served as an Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016.
He also held director positions at Balboa Biosciences, Inc. and Tongli Pharmaceuticals (USA), Inc. Prior to his director roles, he was a Partner at Deloitte LLP (New York) from 1978 to 2006.
Mr. Kaye received his undergraduate degree from Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UNIQURE N.V.
0,05% | 15/09/2023 | 25 419 ( 0,05% ) | 132 179 $ | 31/03/2024 |
| 03/01/2024 | 33 581 ( 0,12% ) | 56 080 $ | 31/03/2024 |
Postes actifs de Jack Kaye
| Sociétés | Poste | Début |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Director/Board Member | 01/05/2015 |
| UNIQURE N.V. | Director/Board Member | 15/06/2016 |
DiaCarta, Inc.
 DiaCarta, Inc. BiotechnologyHealth Technology DiaCarta, Inc. provides novel molecular diagnostics technology and services. Its services include clia lab, NGS target sequencing, next-gen sequencing, companion diagnostics and cart-T immunotheraphy. The company was founded by Paul Okunieff and Aiguo Zhang in 2010 and is headquartered in Richmond, CA. | Director/Board Member | 07/04/2022 |
Anciens postes connus de Jack Kaye
| Sociétés | Poste | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Director/Board Member | 25/05/2016 |
| TONGLI PHARMACEUTICALS (USA), INC. | Director/Board Member | 19/06/2009 |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2006 |
Balboa Biosciences, Inc.
 Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Formation de Jack Kaye
| Baruch College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DYADIC INTERNATIONAL, INC. | Health Services |
| UNIQURE N.V. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Tongli Pharmaceuticals (USA), Inc.
 Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Tongli Pharmaceuticals (USA), Inc. engages in the production, development, and distribution of pharmaceutical healthcare products. The company was founded by Ming Li Yao on November 26, 1999 and is headquartered in Flushing, NY. | Health Technology |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology DiaCarta, Inc. provides novel molecular diagnostics technology and services. Its services include clia lab, NGS target sequencing, next-gen sequencing, companion diagnostics and cart-T immunotheraphy. The company was founded by Paul Okunieff and Aiguo Zhang in 2010 and is headquartered in Richmond, CA. | Health Technology |
